- Home
- ASTL vs IMNM Comparison
ASTL vs IMNM Comparison
Compare ASTL & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTL
- IMNM
- Stock Information
- Founded
- ASTL 1902
- IMNM 2006
- Country
- ASTL Canada
- IMNM United States
- Employees
- ASTL N/A
- IMNM N/A
- Industry
- ASTL Steel/Iron Ore
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- ASTL Industrials
- IMNM Health Care
- Exchange
- ASTL Nasdaq
- IMNM Nasdaq
- Market Cap
- ASTL 733.5M
- IMNM 748.3M
- IPO Year
- ASTL N/A
- IMNM 2020
- Fundamental
- Price
- ASTL $6.63
- IMNM $8.40
- Analyst Decision
- ASTL
- IMNM Strong Buy
- Analyst Count
- ASTL 0
- IMNM 5
- Target Price
- ASTL N/A
- IMNM $26.40
- AVG Volume (30 Days)
- ASTL 944.0K
- IMNM 1.1M
- Earning Date
- ASTL 07-22-2025
- IMNM 08-11-2025
- Dividend Yield
- ASTL 2.94%
- IMNM N/A
- EPS Growth
- ASTL N/A
- IMNM N/A
- EPS
- ASTL N/A
- IMNM N/A
- Revenue
- ASTL $1,635,857,227.00
- IMNM $10,938,000.00
- Revenue This Year
- ASTL $0.95
- IMNM N/A
- Revenue Next Year
- ASTL $21.63
- IMNM $259.34
- P/E Ratio
- ASTL N/A
- IMNM N/A
- Revenue Growth
- ASTL N/A
- IMNM N/A
- 52 Week Low
- ASTL $4.17
- IMNM $5.15
- 52 Week High
- ASTL $12.14
- IMNM $16.81
- Technical
- Relative Strength Index (RSI)
- ASTL 51.03
- IMNM 44.32
- Support Level
- ASTL $6.88
- IMNM $8.40
- Resistance Level
- ASTL $7.14
- IMNM $9.27
- Average True Range (ATR)
- ASTL 0.27
- IMNM 0.46
- MACD
- ASTL -0.07
- IMNM -0.06
- Stochastic Oscillator
- ASTL 28.07
- IMNM 7.06
About ASTL Algoma Steel Group Inc.
Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.